New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 18, 2014
04:55 EDTHUM, GALEStocks with implied volatility movement; GAL HUM
Stocks with implied volatility movement; Galena (GAL) 172, Humana (HUM) 39 according to iVolatility
News For GALE;HUM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
10:51 EDTHUMLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Gupte provides outlook and favorite names for 2015 in the Hospitals and Managed Care Industry on an Analyst/Industry conference call to be held on December 18 at 1 pm.
December 15, 2014
09:01 EDTHUMHumana appoints Cynthia Zipperle as Chief Accounting Officer
Subscribe for More Information
December 12, 2014
13:52 EDTHUMLeerink healthcare services analyst holds an analyst/industry conference call
Subscribe for More Information
December 11, 2014
08:40 EDTGALEGalena presents HER2 screening data results from NeuVax Phase 3 clinical trial
Galena Biopharma announced that initial immunohistochemistry, or IHC, screening data from the NeuVax Phase 3 PRESENT, or Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment, trial was presented at the 2014 San Antonio Breast Cancer Symposium, or SABCS. The poster, entitled, "HER2 Discordant Results in Local vs. Central Testing in the Phase 3 Nelipepimut-S Trial and Implementation of Leica Bond Oracle HER2 Immunohistochemistry System for Low and Intermediate Levels of HER2 Protein Expression as a Companion Diagnostic," demonstrated that with the implementation of the Leica Bond Oracle HER2 IHC assay, preliminary limited data indicated additional patients met HER2 eligibility for PRESENT and the assay identified more precisely patients at HER2 1+ and 2+. As part of the PRESENT trial, Galena has implemented central laboratory testing for all potential patients to confirm validated and robust entry criteria, and ensure the enrollment of the targeted patient population. To improve accuracy and specificity for the HER2 1+ and 2+ status testing, and develop a companion diagnostic for NeuVax, the Leica Bond Oracle HER2 IHC system has been incorporated as central HER2 IHC screening for the PRESENT study.
December 10, 2014
14:45 EDTHUMDeal would block payments to health insurance companies, The Hill says
Subscribe for More Information
10:56 EDTHUMSaint Luke's enters into agreement with Humana
Saint Luke’s Health System and Humana announced an agreement through which Humana will offer a new health insurance plan to Missourians purchasing insurance through the Missouri Health Insurance Marketplace, also known as an exchange.
December 8, 2014
09:20 EDTGALEOn The Fly: Pre-market Movers
Subscribe for More Information
07:08 EDTGALEGalena GALE-401 Phase 1 results show reduced platelet counts, tolerable safety
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use